(Q36607320)

15 August 2017

1 reference

title

Zonisamide for the treatment of epilepsy (English)

1 reference

15 August 2017

Alexis Arzimanoglou

1

1 reference

15 August 2017

Abdallah Rahbani

series ordinal

2

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

1283-1292

1 reference

Overview of Japanese experience-controlled and uncontrolled trials

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Efficacy of zonisamide: our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide in the management of epilepsy--Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide in West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Long-term response to zonisamide in patients with West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide for West syndrome: a comparison of clinical responses among different titration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide clinical trials: European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Use of zonisamide in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide for absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide monotherapy for epilepsy in children and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Safety of zonisamide therapy: prospective follow-up survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Practical prescribing and long-term efficacy and safety of zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

Zonisamide and associated oligohidrosis and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1283

10.1586/14737175.6.9.1283

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference